Explore News
-
GLP-1 Drugs Cut Breast Cancer Recurrence Risk by 29%
New research shows that GLP-1 agonists, widely prescribed for diabetes and obesity, significantly reduce the…
New research shows that GLP-1 agonists, widely prescribed for diabetes and obesity, significantly reduce the…